ANGLE plc (LON:AGL – Get Free Report) traded down 9.4% during mid-day trading on Saturday . The stock traded as low as GBX 14.22 ($0.18) and last traded at GBX 14.50 ($0.18). 1,973,299 shares were traded during trading, an increase of 0% from the average session volume of 1,970,340 shares. The stock had previously closed at GBX 16 ($0.20).
Analyst Upgrades and Downgrades
Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 40 ($0.50) target price on shares of ANGLE in a research note on Wednesday, January 29th.
Get Our Latest Stock Report on AGL
ANGLE Stock Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Featured Stories
- Five stocks we like better than ANGLE
- What is the Hang Seng index?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- Do ETFs Pay Dividends? What You Need to Know
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- How to Calculate Inflation Rate
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.